Demonstrates improved chemotherapy response assessment in pancreatic ductal adenocarcinoma using quantitative CT perfusion, suggesting better patient prognosis.
Our study demonstrates that quantitative CTP is associated with better identification of long-term survivors than RECIST, based on increased peak enhancement after chemotherapy. Quantitative CTP may serve as a valuable complement to current treatment assessment methods in patients with PDAC.
No takes yet. Share an insight, caveat, or question.
Perik et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: